Jefferies Financial Group Inc. Eye Point Pharmaceuticals, Inc. Transaction History
Jefferies Financial Group Inc.
- $20.1 Billion
- Q3 2025
A detailed history of Jefferies Financial Group Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 140,000 shares of EYPT stock, worth $1.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
140,000Holding current value
$1.66 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EYPT
# of Institutions
168Shares Held
68MCall Options Held
454KPut Options Held
401K-
Cormorant Asset Management, LP Boston, MA8.33MShares$98.7 Million18.35% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.19MShares$73.4 Million2.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.56MShares$65.9 Million0.13% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$52.3 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.17MShares$49.4 Million0.02% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $404M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...